enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Velusetrag - Wikipedia

    en.wikipedia.org/wiki/Velusetrag

    Velusetrag (INN, [1] USAN; previously known as TD-5108) is an experimental drug candidate for the treatment of gastric neuromuscular disorders including gastroparesis, and lower gastrointestinal motility disorders including chronic idiopathic constipation and irritable bowel syndrome. [2]

  3. Relamorelin - Wikipedia

    en.wikipedia.org/wiki/Relamorelin

    Relamorelin (INN, USAN) (developmental code names RM-131, BIM-28131, BIM-28163) is a synthetic peptide, centrally penetrant, selective agonist of the ghrelin/growth hormone secretagogue receptor (GHSR) which is under development by Allergan pharmaceuticals for the treatment of diabetic gastroparesis, chronic idiopathic constipation, and anorexia nervosa.

  4. Granisetron - Wikipedia

    en.wikipedia.org/wiki/Granisetron

    The drug was approved in the United Kingdom in 1991 and in United States in 1994 by the FDA. A granisetron transdermal patch with the trade name Sancuso was approved by the US FDA on September 12, 2008. [2] Sancuso is manufactured by 3M Drug Delivery Systems for Kyowa Kirin, Inc. It was patented in 1985 and approved for medical use in 1991. [3]

  5. US FDA declines to approve Vanda's stomach condition drug - AOL

    www.aol.com/news/us-fda-declines-approve-vandas...

    Vanda was seeking the health regulator's nod for the drug, tradipitant, to treat symptoms of gastroparesis, a condition characterized by delayed gastric emptying. The disease is associated with ...

  6. Ozempic users report stomach paralysis as weight loss drug ...

    www.aol.com/ozempic-users-report-stomach...

    Ozempic, a once-weekly injection used for the treatment of type 2 diabetes, has skyrocketed in use after people were reportedly prescribed the FDA-approved diabetes medication as an “off-label ...

  7. Metoclopramide - Wikipedia

    en.wikipedia.org/wiki/Metoclopramide

    Evidence also supports its use for gastroparesis, a condition that causes the stomach to empty poorly, and as of 2010 it was the only drug approved by the FDA for that condition. [6] [18] It is also used in gastroesophageal reflux disease. [6] [4]

  8. FDA approves weight-loss drug to treat sleep apnea - AOL

    www.aol.com/fda-approves-weight-loss-drug...

    The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

  9. Gastroparesis - Wikipedia

    en.wikipedia.org/wiki/Gastroparesis

    Treatment includes dietary modification, medications to stimulate gastric emptying (including some prokinetic agents), medications to reduce vomiting (including some antiemetics), and surgical approaches. [5] Additionally, gastric electrical stimulation (GES; approved on a humanitarian device exemption) can be used as treatment. [6]